ResearcherNanjing Medical UniversityNo recent work listed

Zhi-gang Zhu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0828-6168; OpenAlex author ID A5047230516. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2022: 2 papers

Papers 2

Prognostic signature based on m6A-related lncRNAs to predict overall survival in pancreatic ductal adenocarcinoma. Last author DOI 10.1038/s41598-022-07112-8 ↗
Integrated analysis of senescence-associated genes in pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fgene.2022.941389 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dong-liu Miao · 2 shared papers, 2022 · strength 0.40
- Paper Prognostic signature based on m6A-related lncRNAs to predict overall survival in pancreatic ductal adenocarcinoma. DOI 10.1038/s41598-022-07112-8 ↗
- Paper Integrated analysis of senescence-associated genes in pancreatic ductal adenocarcinoma. DOI 10.3389/fgene.2022.941389 ↗
Qiong Wu · 1 shared paper, 2022 · strength 0.20
- Paper Integrated analysis of senescence-associated genes in pancreatic ductal adenocarcinoma. DOI 10.3389/fgene.2022.941389 ↗
Qiong Wu · 1 shared paper, 2022 · strength 0.20
- Paper Prognostic signature based on m6A-related lncRNAs to predict overall survival in pancreatic ductal adenocarcinoma. DOI 10.1038/s41598-022-07112-8 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.